Omalizumab had the greatest risk for adverse effects and dupilumab had the most favorable safety profile among biologics for patients with asthma, according to an abstract presented at the CHEST ...

For decades, scientists believed molecules called leukotrienes were the main culprits behind asthma’s airway-constricting inflammation. But new research suggests that “pseudo leukotrienes” may ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Researchers captured how caregivers view oral ...

Allergen immunotherapy (AIT) for allergic rhinitis and asthma is effective long-term, according to a literature review of real-world evidence by researchers in Germany and Poland. "Real-world data for ...

Learn about common asthma triggers, from dust mites to food allergens, that may be hiding in your child’s backpack, and ...

Social determinants of health (SDoH) are independent risk factors for asthma, according to a study published online Oct. 24 ...

Thomas Jefferson University scientist Raymond Penn spends his days searching for the molecules that could be the key to better asthma treatments. He’s invested decades into this goal, for which stakes ...

Patients with asthma and T2 diabetes using SGLT2 inhibitors have a significantly decreased mortality risk within 30 days of an asthma exacerbation.

A phase 4 study found severe asthma can be controlled using biologic therapies, without the addition of high-dose inhaled steroids. Among a cohort of patients with severe asthma using the biologic ...

Many parents fear childhood asthma inhalers due to myths. This article debunks common misconceptions, explaining that inhalers are not addictive and ...

Tezspire (tezepelumab-ekko) is a monthly injection used to treat severe asthma. It was approved by the FDA in 2021 for use in addition to other asthma controlling medicines in people 12 and older.